Table 2.
Group of Hybrid Healthcare | Group of In-Person Healthcare | p-Value | |||
---|---|---|---|---|---|
Variable | Yes | % Yes | Yes | % Yes | |
Experiencing difficulties accessing medical care because of pandemic. | 244 | 83.28% | 208 | 64% | <0.001 |
Primogeniture. | 126 | 43% | 225 | 69.23% | <0.001 |
Diagnosed gestational diabetes mellitus (GDM). | 55 | 18.77% | 44 | 13.54% | 0.077 |
Diagnosed hypothyroidism during pregnancy. |
86 | 29.35% | 71 | 21.85% | 0.032 |
Diagnosed anemia during pregnancy. |
52 | 17.75% | 53 | 16.31% | 0.634 |
Ultrasound before 10 weeks of gestation. | 276 | 94.2% | 302 | 92.92% | 0.520 |
Ultrasound screening between 11 and 13 + 6 weeks of gestation. |
285 | 97.27% | 318 | 97.85% | 0.642 |
Double marker test. | 186 | 64.48% | 178 | 54.77% | 0.028 |
Ultrasound screening between 18 and 22 weeks of gestation. |
269 | 91.81% | 286 | 88% | 0.118 |
Fasting glucose test. | 273 | 93.17% | 301 | 92.61% | 0.787 |
OGTT. | 233 | 79.52% | 237 | 72.92% | 0.055 |
Ultrasound screening between 28 and 32 weeks of gestation. |
215 | 73.38% | 205 | 63.08% | 0.006 |